Quantum BioPharma Financials

$3.24

$0.29 (9.83%)

As on 04-Sep-2026 16:10EDT

Market cap

$21 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-8.38	-6.88	-10.83	-28.33	-20.75
Cash Flow from Investing Activities	--	-1.99	-1.50	-0.27	12.12	0.27
Cash from Financing Activities	--	6.21	11.62	-3.13	-2.07	38.21
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-5.63	-5.63	-6.73	-13.82	-29.54	-39.50
Cash EPS ($)	-4.89	-4.89	-6.59	-13.35	-25.41	-31.91
Adjusted Book Value ($)	1.05	1.05	1.78	11.17	21.84	51.10
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-2.16	-6.69	-17.87	-47.40
Free Cash Flow per Share ($)	--	--	-2.16	-6.69	-17.87	-48.01

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	--	-248.22	-109.75	-80.22	-55.06
ROE (%)	-333.30	-333.30	-284.63	-114.92	-81.78	-55.76
ROA (%)	-97.21	-97.21	-185.25	-82.11	-64.07	-46.57
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	11.62	11.62	-77.15	18.44	31.61	21.30
Net Profit Growth (%)	78.25	5.01	-84.30	20.66	24.17	33.10
EPS Growth (%)	71.83	71.83	0.51	0.53	0.25	0.35
Book Value Growth (%)	-4.18	-4.18	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	-1.08	-0.27	-2.02	-1.30
Price / Book Value	--	--	4.11	0.33	2.74	1.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.57	-1.57	-0.93	0.18	-2.10	-0.64
Close Price ($)	3.62	3.62	7.30	3.68	59.80	51.22
High Price ($)	31.91	31.91	38.25	70.85	136.50	72.15
Low Price ($)	2.07	2.07	2.89	2.70	49.53	40.17
Market Cap ($ Cr)	20.83	20.83	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.27	0.07	0.03	0.02
Short term debt to equity ratio	0.12	0.12	0.27	0.07	0.03	0.02
Current Ratio	1.20	1.20	1.07	1.80	2.43	2.28
Quick Ratio	1.19	1.19	1.06	1.79	2.43	--
Interest Coverage	-53.83	-53.83	-42.57	-312.50	-60,970.87	-545.96

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	55.67	43.65	--	--
Payable days	--	--	1,722.12	2,418.08	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.